DS

Dipti Saxena

Active Director Director DIN 09052478
DIN 09052478 First appointment Feb 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2021
Shareholding value •••• Premium profile

About Dipti Saxena

Data last updated:

Dipti Saxena is a Director at Mantak Life Sciences Private Limited (since 2021). The company operates in Chemicals. Mantak Life Sciences Private Limited reported revenue of ₹16.4 Lakh (FY 2026).

DIN 09052478
Primary Designation Director
Industry Chemicals
First Appointment 03 Feb 2021
Oldest Company Age 5 yrs
Largest company Mantak Life Sciences Private Limited · ₹16.4 Lakh (FY 2026)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mantak Life Sciences Private Limited U24290UP2021PTC141225
Director03 Feb 20212021₹16.4 Lakh (FY 2026)Active

Board colleagues of Dipti Saxena

Directorship timeline

Open interactive timeline →
Mantak Life Sciences Private Limited
Premium access

Shareholding and investment profile for Dipti Saxena

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dipti Saxena

Dipti Saxena currently holds 1 directorship: Mantak Life Sciences Private Limited (Director, since 03 Feb 2021, revenue ₹16.4 Lakh (FY 2026)).

Dipti Saxena was first appointed on 03 Feb 2021 as Director at Mantak Life Sciences Private Limited.

The current boards of Dipti Saxena's companies include Piyush Saxena (Mantak Life Sciences Private Limited), Sachin Saxena (Mantak Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available